CDCA4 Antikörper (N-Term)

Produktnummer ABIN321807

Produktdetails anti-CDCA4 Antikörper

Target: CDCA4 (Cell Division Cycle Associated 4 (CDCA4))

Bindungsspezifität: N-Term

Reaktivität: Human, Affe

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CDCA4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: Human CDCA4

Homologie: Percent identity by BLAST analysis: Human (100%) Mouse, Rat (91%).

Aufreinigung: Protein A purified

Immunogen: Synthetic peptide from N-Terminus of human CDCA4 (Q9BXL8, NP_060425). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Marmoset, Stickleback (100%), Mouse, Rat, Hamster (91%), Galago (84%).

Type of Immunogen: Synthetic peptide

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: WB

Usage: ELISA titer using peptide based assay: 1:1562500. Western Blot: Suggested dilution at 2.5 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1:50000 - 100000 as second antibody.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Distilled Water.

Konzentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Handhabung: Avoid repeat freeze-thaw cycles.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Details zu CDCA4

Target: CDCA4 (Cell Division Cycle Associated 4 (CDCA4))

Andere Bezeichnung: CDCA4 (CDCA4 Produkte)

Synonyme: HEPP antikoerper, SEI-3/HEPP antikoerper, 2410018C03Rik antikoerper, SEI-3 antikoerper, cell division cycle associated 4 antikoerper, cell division cycle associated 4 L homeolog antikoerper, CDCA4 antikoerper, cdca4 antikoerper, cdca4.L antikoerper, Cdca4 antikoerper

Hintergrund: Name/Gene ID: CDCA4

Synonyms: CDCA4, HEPP, SEI-3/HEPP

Gen-ID: 55038

NCBI Accession: NP_060425

UniProt: Q9BXL8